KK2223 Clinical Trials (2026): 1 Studies for T-cell NHL (PTCL or CTCL)
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 KK2223 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including T-cell NHL (PTCL or CTCL)) and 72 total planned enrollment. 1 KK2223 clinical trial is actively recruiting. Most recent activity: NCT07192471 (Sep 2030).
KK2223 clinical trials at a glance: phase × recruitment status
| Phase | not yet recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting KK2223 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07192471 | A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma | P1 | T-cell NHL (PTCL or CTCL) | 72 | Jul 2026 |
All KK2223 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07192471 | A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma | P1 | not yet recruiting | 72 | Kyowa Kirin, Inc. | Jul 2026 |
KK2223 clinical trials: frequently asked questions
- How many KK2223 clinical trials are there?
- 1 KK2223 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov.
- Are KK2223 clinical trials recruiting in 2026?
- No active KK2223 trials are recruiting on ClinicalTrials.gov as of the current AACT refresh. Trials may resume; this page is updated daily.
- What conditions is KK2223 being studied for?
- KK2223 is being studied for T-cell NHL (PTCL or CTCL). The trials are grouped by indication on this page.
- What phase is KK2223 in?
- KK2223 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors KK2223 clinical trials?
- The lead sponsor across the most KK2223 trials is Kyowa Kirin, Inc.. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming KK2223as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: